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NanoencapsulationThe aim of this study was to produce bixin nanocapsules by the interfacial deposition of preformed poly-
e-caprolactone (PCL). PCL (250 mg), capric/caprylic triglyceride (400 lL), sorbitan monostearate (95 mg)
and bixin were dissolved in a mixture of acetone (60 mL) and ethanol (7.5 mL) under stirring (40 C). This
organic solution was added to the aqueous solution (130 mL) containing Tween 80 (195 mg). The size dis-
tributions in the formulations with bixin concentration from 11 to 100 lg/mL were evaluated periodi-
cally during 3 weeks of storage at ambient temperature. The optimal formulation (bixin concentration
of 16.92 ± 0.16 lg/mL) was characterised in terms of particle size distribution, zeta potential, bixin con-
tent and encapsulation efﬁciency, and showed a volume-weighted mean diameter (D4,3) of 195 ± 27 nm,
around 100% of encapsulation efﬁciency and the nanocapsules were considered physically stable during
119 days of storage at ambient temperature.
 2013 Elsevier Ltd. All rights reserved.1. Introduction
Annatto is a natural colourant that is mostly used in food prod-
ucts because of its low cost and high-quality sensorial characteris-
tics, such as cheeses, ice creams, butters and meats (Cardarelli,
Benassi, & Mercadante, 2008). The primary colouring component
found in annatto seeds is bixin, a carotenoid formed by nine conju-
gated double bonds and two carboxylic groups (Fig. 1). The struc-
ture of bixin is responsible not only for its light absorption and
antioxidant activity but also for its poor water-solubility, which
impairs its use in low-fat foods (Rodriguez-Amaya, 2001).
Like other carotenoids, bixin is an efﬁcient quencher of singlet
oxygen and a scavenger of reactive species of oxygen and nitrogen
(Chisté et al., 2011; Rios, Antunes, & Bianchi, 2009; Rios, Merca-
dante, & Borsarelli, 2007). Bixin is considered to be unstable in
the presence of oxygen, heat and light. However, some studies
showed that the techniques of complexation and encapsulation de-
crease the degradation rate of bixin caused by light, air, ozone, oxy-
gen and high temperature (Barbosa, Borsarelli, & Mercadante,
2005; Lyng, Passos, & Fontana, 2005; Marcolino, Zanin, Durrant,
Benassi, & Matioli, 2011; Parize et al., 2008).
In general, encapsulation improves the stability, solubility and
bioavailability of encapsulated species and promotes its controlled
release (Paese et al., 2009; Shaikh, Ankola, Beniwal, Singh, & Ravi
Kumar, 2009; Zuidam & Shimoni, 2010). Nanoencapsulation is aprocess by which one compound is covered by another, producing
particulate dispersions or solid particles, with sizes ranging from
10 nm to 1 lm. Depending upon the method of preparation of
nanoparticles, nanospheres or nanocapsules can be obtained. Nano-
capsules are systems in which the bioactive compound is soluble in
the core, conﬁned to a cavity surrounded by a polymer membrane,
while nanospheres are matrix systems in which the drug is physi-
cally and uniformly dispersed (Mohanraj & Chen, 2006).
Nanocapsule systems are used for the delivery of drugs, pep-
tides, proteins, genes, etc., and several compounds have been
encapsulated (Couvreur, Barratt, Fattal, Legrand, & Vauthier,
2002). In the literature a number of methos are cited; most nano-
particles have been mainly prepared by dispersion of preformed
polymers, polymerisation of monomers and ionic gelation or coac-
ervation of hydrophilic polymers (Mohanraj & Chen, 2006).
For carotenoids, most research has been dedicated primarily to
the encapsulation of b-carotene. Qian, Decker, Xiao, and McCle-
ments (2012) studied the effects of adding ascorbic acid, vitamin
E acetate, coenzyme Q10 and ethylenediametetraacetic acid
(EDTA) on the inhibition of b-carotene degradation in oil-in-water
nanoemulsions. Silva et al. (2011) produced nanoemulsions of b-
carotene using a high-energy emulsiﬁcation-evaporation tech-
nique, studied the effect of processing variables (homogenisation
time, shear rate and number of cycles), and evaluated the stability
during storage.
The bixin encapsulation has been studied by Parize et al. (2008)
and Barbosa et al. (2005). Parize et al. produced, characterised and
evaluated the thermal stability of the urucum pigment (containing
Fig. 1. Structure of cis-bixin (methyl hydrogen 90-cis-6,60-diapocarotene-6,60-
dioate).
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using chitosan as encapsulating agent in different solutions (acetic
acid 5%, lactic acid 5% and citric acid 5%), and Barbosa, Borsarelli,
and Mercadante (2005) evaluated the light stability of spray-dried
bixin encapsulated with gum arabic or maltodextrin. However, to
date, no studies have been published on the production and stabil-
ity evaluation of bixin nanocapsules.
Indications that bixin may be important to human health and
bixin’s prevalence in the food industry as a colourant and antioxi-
dant motivates the study of nanoencapsulation as a suitable tech-
nique for increasing the solubility of bixin in aqueous media.
Therefore, the aim of this work was to prepare and characterise
bixin nanocapsules and to evaluate their stability during storage.
2. Materials and methods
2.1. Materials
The polymer poly-e-caprolactone (PCL) (Mw = 80,000) and sor-
bitan monostearate (Span 60) were obtained from Sigma (St. Louis,
MO, USA). The capric/caprylic triglycerides (CCT) and polysorbate
80 (Tween 80) were purchased from Delaware (Porto Alegre, Bra-
zil). Annatto seeds were obtained from the local market in Porto
Alegre, Brazil. All other chemicals and solvents were of analytical
or pharmaceutical grade.
2.2. Bixin standard
A bixin standard was prepared in triplicate according to the
method of Rios and Mercadante (2004). This method consisted in
the production of a bixin standard extracted from annatto seeds.
Annatto seeds (25 g) were twice washed with hexane (100 mL).
The solvent was discarded and the seeds were washed twice with
methanol (100 mL). Methanol was also discarded and bixin was
extracted from the seeds with ethyl acetate (100 mL). Each wash
or extraction was carried out under magnetic stirring during
15 min. The extract was ﬁltered and concentrated under reduced
pressure in a rotary evaporator (Fisatom, model 801/802, São Pau-
lo, SP, Brazil). After concentration, the recipient containing the ex-
tract was placed in a cold bath and dichloromethane (5 mL) was
added slowly to this extract. After the addition of dichloromethane,
ethanol (99.7%) was added slowly (20 mL). This solution was held
at 18 C during 12 h for crystallisation. The crystals formed in the
bottom of the recipient were ﬁltered, washed with 50 mL of etha-
nol (99.7%) and dried under reduced pressure (T < 30 C). The pur-
ity of the standard was evaluated by high performance liquid
chromatography (HPLC).
2.3. Bixin nanocapsules
Bixin nanocapsules were prepared by the technique of interfa-
cial deposition of preformed polymers according to the method
of Venturini et al. (2011). The polymer (PCL) (250 mg), triglycerides
(CCT) (400 lL), span 60 (95 mg) and bixin were dissolved in a mix-
ture of acetone (60 mL) and ethanol (7.5 mL) under magnetic stir-
ring at 40 C. After the solubilisation of PCL, CCT and Span 60, thestandard of bixin (98.7%) was added and remained under magnetic
stirring for 10 min (40 C). This organic phase was added into an
aqueous phase (130 mL) containing Tween 80 (195 mg) and re-
mained under stirring for 10 min. The dispersion was concentrated
under reduced pressure until it reached a ﬁnal volume of 25 mL. In
this method, acetone and ethanol (a water-miscible solvent) were
used to solubilise PCL and Span 60. As the solvents migrate to the
aqueous phase, an interfacial turbulence is created due to the
spontaneous diffusion between the phases leading to the sponta-
neous formation of nanocapsules. As the concentration of water
miscible solvent increases, a decrease in the size of particle can
be achieved (Mohanraj & Chen, 2006).
In preliminary tests, the bixin concentrations tested in the bixin
nanocapsule formulations were 100, 58, 37, 16 and 11 lg/mL;
these were stored under ambient conditions (25 ± 1 C) in amber
glasses, and the parameter of size distribution was evaluated peri-
odically during three weeks.
Based on the nanocapsules stability, an optimal formulation
was prepared in triplicate and was characterised in terms of viscos-
ity, bixin content, encapsulation efﬁciency, pH, diameter, zeta-po-
tential and colour. Moreover, the stability of the optimum
formulation was studied during storage at ambient temperature.
The pH, diameter and bixin concentration were evaluated weekly
for 9 weeks; after this period, the evaluation was performed every
2 weeks up to 119 days of storage.
2.4. Viscosity
The viscosity of the bixin nanocapsule suspension was mea-
sured immediately after preparation using a Brookﬁeld rotational
viscometer (model DV-II + Pro, spindle LV2, Brookﬁeld Engineer-
ing, USA) at 25 C. Data were analysed using Brookﬁeld Rheocalc
32 software.
2.5. Colorimetric analysis
The bixin nanocapsule suspension (optimal formulation)
(10 mL) and a free bixin solution (10 mL) were analysed using a
portable colorimeter (Konica Minolta model CR 400, Singapore).
Both samples were prepared in triplicate in the same bixin concen-
tration (16.92 lg/mL). The free bixin was solubilised in etha-
nol:water (2:8) due to the low solubility of bixin in pure water.
The colorimetric parameters were obtained according to the
Comission Internationale de l’Eclairage (CIELAB system); the coor-
dinates were L⁄ (lightness), and the colour coordinates a⁄ (red-
green component) and b⁄ (yellow-blue component), which were
measured using the illuminant D65 and an angle of viewing of 0.
2.6. Encapsulation efﬁciency
The total content of bixin was determined through the extrac-
tion of bixin from the bixin nanocapsule suspension. This method
consisted of the extraction from an aliquot of 250 lL of formula-
tion with acetonitrile (4.75 mL). This extract was sonicated by
ultrasound (30 min) and centrifuged (15 min at 2820g). The
supernatant was injected in the HPLC. The bixin content in the
aqueous phase of the bixin nanocapsule suspension was deter-
mined through the injection of the ﬁltrate in the HPLC. The ﬁltrate
was obtained after the ultraﬁltration/centrifugation of an aliquot of
bixin nanocapsule suspension (400 lL) using a Ultrafree-MC
(10,000 MW, Millipore, Bedford, USA) in a centrifuge (15 min at
1690g). The encapsulation efﬁciency was determined according
to the method of Venturini et al. (2011), by dividing the difference
between the total concentration of bixin and the concentration of
bixin in the aqueous phase by the total concentration and multi-
plying the results by 100.
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Analyses were carried out using an HPLC system (Agilent series
1100, Santa Clara, CA, USA) equipped with an online degasser, a
quaternary pump and an automatic injector and that was coupled
to a C18 Spherisorb ODS-2 column (150  4.6 mm i.d.; 3 lm parti-
cle size), adjusted at 25 C. Data acquisition and processing were
performed using the CHEMSTATION software programme. Bixin
was eluted isocratically at a ﬂow rate of 1 mL/min using acetoni-
trile/2% v/v acetic acid/dichloromethane (63:35:2 v/v) as the mo-
bile phase. The chromatograms were processed at the maximum
absorption wavelength of bixin (470 nm).
All of the solvents used in the HPLC separation were of chro-
matographic grade and previously ﬁltered through a Millipore vac-
uum ﬁltration system using a 0.22 lm membrane for organic
solvents (Millipore, Barueri, SP, Brazil). The injections were per-
formed in duplicate.
Before being injected, the bixin standard was diluted in acetoni-
trile and the content of bixin in the nanosuspension (250 lL) was
extracted with acetonitrile (4.75 mL), homogenised by ultrasonica-
tion (30 min) and centrifuged (15 min at 2820g). The content of
bixin present in the aqueous phase was separated from the bixin
nanocapsule suspension after ultraﬁltration-centrifugation
(15 min at 1690g). The aqueous phase was directly injected in
the HPLC without dilution. All samples were ﬁltered before the
injections (0.45 lm, Millex with modiﬁed PTFE membrane for
aqueous and organic solvents, Millipore, Barueri, São Paulo, Brazil).
For the quantiﬁcation of bixin, a standard curve with a determi-
nation coefﬁcient (R2) greater than 0.99 was used. This standard
curve was obtained plotting the peak areas (from the HPLC) of ﬁve
solutions containing different concentrations of bixin (from 1.37 to
80.16 lg/mL) quantiﬁed previously by a spectrophotometer (UV–
Visible Agilent 8453, Santa Clara, CA, USA) at 470 nm with an
absorptivity coefﬁcient of 2,826 in chloroform. The limits of detec-
tion (LOD) and quantiﬁcation (LOQ) were 0.231 and 0.235 lg/mL,
respectively, and were determined according to the method de-
scribed by Long and Winefordner (1983).2.8. pH
The pH of the bixin nanocapsule suspension was measured at
25 C using a DM-22 potentiometer (Digimed, Brazil).2.9. Determination of diameter and zeta potential
The nanocapsules mean diameter (z-average) and polydisper-
sity index (PDI) were measured at 25 C by Dynamic Light Scatter-
ing (DLS) and the zeta potential was measured by electrophoretic
mobility (Zetasizer nano-ZS ZEN mod. 3600, Nanoseries, Malvern,
UK). The samples were appropriately diluted with a pre-ﬁltered
(0.45 lm) 10 mM NaCl aqueous solution or with MilliQ water to
determine the zeta potential and mean diameter (z-average),
respectively. Data analysis was performed using Dispersion Tech-
nology Software (version 4.0, 2002, Malvern Instruments ltd).
The mean diameter of the bixin nanocapsules was also mea-
sured by laser diffraction (LD) (Mastersizer 2000 5.54, Malvern
Instruments, UK), using water as dispersant. The refractive indexes
used for the polymer and for water were of 1.590 and 1.330,
respectively. The data were analysed by Mastersizer 2000 5.54
software programme. The span values were determined by divid-
ing the difference between D0,1 and D0,9 by D0,5, as provided by
the software. The use of DLS and LD was applied as a good means
to evaluate changes during storage because Zetasizer nano ZS and
Mastersizer 2000 are able to determine particle sizes ranging
from 0.003 to 10 lm and from 0.02 to 2000 lm, respectively.2.10. Statistical analysis
The results were evaluated by a one-way analysis of variance
(ANOVA) and the mean values analysed by Tukey’s test using the
STATISTICA 8.0 software programme.3. Results and discussion
3.1. Bixin standard
The purity of the bixin standard was 98.7 ± 0.20%. This value is
similar to the values reported by Rios and Mercadante (2004), Rios
et al. (2009) and Barbosa et al. (2005) who observed purity levels of
98%, 96% and 94%, respectively. These values indicate that the type
of solvent and the characteristics of extraction, such as crystallisa-
tion and temperature, affect the ﬁnal purity in terms of bixin. The
bixin standard was produced with a yield of 0.86 ± 0.03% as a result
of the washing procedures performed to increase the purity.3.2. Preliminary tests of bixin encapsulation
The standard formulation of nanocapsules applied in this study
was chosen because as the polymer PCL is biocompatible, biode-
gradable, and does not generate toxic compounds; moreover, it is
approved by FDA (Food and Drugs Administration) for speciﬁc
studies and has similar costs compared to other synthetic poly-
mers. Moreover, this formulation was studied in various pharma-
ceutical experiments of drug delivery (Jäger et al., 2009; Paese
et al., 2009; Pohlmann et al., 2002). This formulation was opti-
mised by Venturini et al. (2011) in a study in which aqueous sus-
pensions composed exclusively of lipid-core nanocapsules were
formulated, and allows the controlled release of its core content
in the gastrointestinal tract (Frozza et al., 2010).
Preliminary tests were conducted to produce suspensions com-
posed only of bixin nanocapsules with diameters smaller than
1 lm and exhibiting a monomodal size distribution. The formula-
tions were analysed by laser diffraction over a period of 3 weeks.
In the study, ﬁve formulations denoted 1–5 and containing bixin
concentrations of 100, 58, 37, 16 and 11 lg/mL, respectively, were
produced.
Immediately after the preparation, formulation 1 (100 lg/mL)
showed bixin crystals in suspension. The crystallisation process
was induced by high-purity bixin, which resulted from the high
concentration of the bixin standard. Formulation 2 (58 lg/mL)
showed a bimodal size distribution, with particle sizes ranging
from the nanometre to the micrometre scale (Fig. 2a). Differently,
formulation 3 (37 lg/mL) showed a good monomodal distribution
proﬁle, a volume-weighted mean diameter (D4,3) of 151 nm and a
span value of 1.284; moreover, 90% of the nanocapsules had diam-
eters (D0,9) smaller than 115 nm. However, after 5 days of storage,
this formulation showed an unstable behaviour, showing a bimo-
dal size distribution and size larger than 1 lm (Fig. 2b).
Immediately after being produced and over 3 weeks of storage,
both formulations 4 (16 lg/mL) and 5 (11 lg/mL) presented a
monomodal distribution (in terms of volume and number of parti-
cles), with a mean diameter less than 1 lm (Fig. 3a and b). The vol-
ume-weighted mean diameters (D4,3) observed in formulations 4
and 5 were 208 and 163 nm, with span values of 1.397 and
1.271, respectively.
Span values are related to the particle distributions. Low span
values indicate a narrowed particles size distribution (more homo-
geneous sizes). Thus, formulation 5 may be considered to be more
homogeneous because it presented a narrower particle size distri-
bution than that of formulation 4. The results of the cumulative
distribution show that 90% of the nanocapsules in formulations 4
Fig. 2. Bixin nanocapsules size distribution of formulation 2 immediately after preparation (a) and of formulation 3 after 5 days of storage at ambient temperature (b).
Fig. 3. Bixin nanocapsules size distribution obtained by laser diffraction of formulation 4 by volume (a) and number (c); and bixin nanocapsules size distribution of
formulation 5 by volume (b) and number with their respective accumulated distribution (d).
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respectively (Fig. 3c and d).
After 3 weeks of storage, no changes were observed in the mean
diameter of the nanocapsules in formulations 4 and 5, and both
formulations were considered physically stable. However, formu-
lation 4 was chosen for further experiments because of the higher
concentration of bixin measured, in addition to having satisfactory
size and distribution characteristics.
The concentration of bixin in the nanocapsules affected the
physical characteristics of the nanocapsules, such as their
diameter, particle-size distribution and stability, hence, the results
of our preliminary tests show that there is a limit of bixin
solubilisation.
Determining the particle size distribution with respect to parti-
cle volume allowed us to verify the presence of particles with
diameters greater than 1 lm. This veriﬁcation is practically void
when analysing the distributions in terms of number of particles
because these particles (diameter >1 lm) are present in small
amounts.3.3. Characterisation and stability evaluation of bixin nanocapsules
The bixin nanocapsule suspension was prepared in triplicate
with a mean bixin concentration of 16.92 ± 0.16 lg/mL. Venturini
et al. (2011) produced lipid-core nanocapsules with higher concen-
tration of indomethacin ethyl ester (1 mg/mL) using the same
formulation components, which indicated that the type of com-
pound which is encapsulated affected the amount incorporated
into the formulation. However, the concentration of bixin was
not considered low because food dyes are normally used in low
concentrations.
The quantity of a compound that can be incorporated into nano-
encapsulated systems is affected by the type of formulation and
technique used (Ribeiro, Chua, Ichikawa, & Nakajima, 2008; Tan
& Nakajima, 2005; Yuan, Gao, Zhao, & Mao, 2008). In the aqueous
phase of the bixin nanocapsules formulation, the bixin concentra-
tion was below the limit of detection of 0.231 lg/mL (None bixin
peak was found). The mean total concentration of bixin in the for-
mulations was of 16.92 ± 0.16 lg/mL. The encapsulation efﬁciency
Fig. 4. pH variation of bixin nanocapsule suspension over 119 days of storage in
ambient temperature. Standard deviations are represented by bars.
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ciency = [(16.92–0.00)/16.92]  100. Thus, the value of encapsula-
tion efﬁciency is around 100% or greater than 98.63% if the limit
of detection is subtracted from the total concentration of bixin.
The high encapsulation efﬁciency indicates that all bixin in the sus-
pension was present in the nanocapsule structure (inner part and
wall).
Such high encapsulation efﬁciency occurred probably due to the
nanocapsule core which contains triglycerides (CCT), which facili-
tates solubilisation of bixin; this further indicates that nanoencap-
sulation is an effective technique for improving the solubilisation
of bixin in aqueous media. The microencapsulation of bixin in dif-
ferent food polymers has been reported to achieve a maximum
efﬁciency of 86.4% (Barbosa et al., 2005).
The optimal bixin nanocapsule suspension presented a yellow
colour with the following CIELAB coordinates of L⁄ = 73.67 ± 0.34,
a⁄ = 6.01 ± 0.24 and b⁄ = 48.60 ± 0.95. Compared to the pure bixin
solution prepared in ethanol:water (20:80), with parameters
L⁄ = 42.10 ± 0.35, a⁄ = 13.54 ± 0.98 and b⁄ = 25.50 ± 2.2, the bixin
nanocapsule suspension presented an increase in luminosity and
yellow colour, which was coupled with a decrease in red colour.
The viscosity of a suspension is important because the rheolog-
ical properties affect all stages of manufacture such as mixing,
pumping, ﬁlling and are valuable tools in quality control. The
behaviour of the bixin nanocapsule suspension in this study is typ-
ical for a Newtonian ﬂuid, since the increase of the shear stress was
proportional to the increase of the shear rate. The optimal bixin
nanocapsule formulation (16.92 ± 0.16 lg/mL) presented a viscos-
ity of 11.4 ± 0.24 mPa.s.
Immediately after being produced, the bixin nanocapsule sus-
pension showed a mean pH of 5.89 ± 0.70. Paese et al. (2009) used
the same formulation to evaluate in vitro the effectiveness of nano-
encapsulated benzophenone-3 and produced nanocapsule suspen-
sions with pH values of 6.56 ± 0.09, while Pohlmann, Weiss,
Mertins, Silveira, and Guterres (2002) produced indomethacin-
loaded nanocapsule suspensions with pH values of 4.2 ± 0.1 in a
study aiming to apply the spray-drying technique to produce dried
nanocapsules and nanospheres prepared by the technique of inter-
facial deposition of preformed polymer, using a similar formulation
to that used in this work.
One way to evaluate the chemical stability of a nanocapsule
suspension is the measurement of the pH, since its decrease can
be related to the degradation of the polymer or other ingredient
(Kishore et al., 2011; Mallin, Vainio, Karjalainem, & Seppala,
1996). During the ﬁrst 63 days of storage, no signiﬁcant change
was observed in the pH values (p < 0.05); however, on the 119th
day, the pH levels decreased to 4.48 ± 0.32 (Fig. 4). One way to
minimise the changes in pH is to use a buffering agent in the aque-
ous phase. In a previous study, indomethacin nanocapsule suspen-
sions also showed reduced pH values during storage (3 months)
that varied from 4.2 ± 0.1 to 3.4 ± 0.0 and 3.2 ± 0.0 at room temper-
ature and at 50 C, respectively (Pohlmann et al., 2002). The de-
crease in pH values is normal for this type of formulation
because of the liberation of polyester monomer during poly-e-cap-
rolactone hydrolysis (Mallin et al., 1996).
Another explanation for the decrease in the pH is the probable
formation of different compounds like acetic acid, formic acid,
octanoic acid and nonanoic acid during the degradation of polysor-
bate 80 by auto-oxidation in aqueous media. The initiation of auto-
oxidation in polysorbates could occur by the presence of residual
peroxides, metal traces and incidence of light (Kishore et al., 2011).
The term ‘‘emulsion stability’’ refers to the ability of an emul-
sion to resist changes in its properties over time. An emulsion
may become unstable due to a number of different types of phys-
ical and chemical processes. Physical instability results in an alter-
ation in the spatial distribution or structural organisation of themolecules (creaming, ﬂocculation, coalescence, partial coalescence,
phase inversion, and Ostwald ripening), whereas chemical instabil-
ity results in an alteration in the chemical structure of the mole-
cules (oxidation and hydrolysis) (McClements, 1999).
The zeta potential is the result of the components used in the
production of particles, like the surfactants located at the interface
between the continuous and disperse phases, and is commonly
used to characterise the surface charge property of nanoparticles
(Couvreur et al., 2002). Zeta potential reﬂects the electrical poten-
tial of particles and is inﬂuenced by the composition of the particle
and the medium in which it is dispersed. Nanoparticles with a zeta
potential above (±) 30 mV have been shown to be stable in suspen-
sion, as the surface charge prevents aggregation of the particles
(Mohanraj & Chen, 2006). The magnitude and sign of the electrical
charge on an emulsion droplet depend on the type of emulsiﬁer,
the concentration and the prevailing environmental conditions
(e.g., pH, temperature, and ionic strength) (McClements, 1999).
The bixin nanocapsule suspension presented a mean zeta po-
tential of 14.45 ± 0.92 mV immediately after preparation, and
after 119 days of storage decreased to 25.85 ± 6.58 mV. Jäger
et al. (2009) studied the inﬂuence of the concentration of sorbitan
monostearate and polysorbate 80 on the indomethacin ethyl ester
release kinetic and produced formulations using PCL with zeta po-
tential values from 8.6 ± 0.1 to 12.7 ± 2.5 mV. Benzophenone-3-
loaded lipid core nanocapsule suspension prepared with PCL and
Tween 80 showed zeta potentials of 9.5 ± 1.0 mV. The change in
the charge probably occurred due to the hydrolysis of polysorbate
80, since the negative zeta potential is a consequence of the nega-
tive charge density of the carboxylate groups in the PCL backbone
(Paese et al., 2009).
The objective of producing particles exclusively on the nanome-
tre scale was achieved, as indicated by the laser diffraction analy-
ses, which showed a narrow monomodal distribution of bixin
nanocapsules, with a volume-weighted mean diameter (D4,3) of
195 ± 27 nm, a surface-weighted mean diameter (D3,2) of
138 ± 13 nm and span value of 1.4 ± 0.1. In addition, 90% of the
nanocapsules (D0.9) presented diameters smaller than 124 ± 5 nm.
In evaluating certain process variables (homogenisation pres-
sure, number of cycles and organic/aqueous phase relation), Tan
and Nakajima (2005) produced b-carotene nanodispersions by sol-
vent displacement method using Tween 20 as emulsiﬁer, with
mean diameters (D4,3) varying from 60 to 135 nm and with span
values varying from 0.4 to 0.7. Ribeiro et al. (2008) used food grade
materials, gelatin and Tween 20 to produce polymeric nanodisper-
sions of b-carotene with mean diameters (D3,2) ranging from 74 to
77 nm.
The dynamic light scattering analyses also demonstrated that
the bixin nanocapsules presented a monomodal distribution with
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index of 0.098 ± 0.03. The PDI values ranging from 0.1 to 0.25 indi-
cates a narrow size distribution while a PDI greater than 0.5 is re-
lated to a broad distribution (Wu, Zhang, & Watanabe, 2011). Paese
et al. (2009) produced nanocapsules with mean diameters (z-aver-
age) of 247 ± 4 nm and a polydispersity index lower than 0.2. Yuan
et al. (2008), applied the technique of high pressure homogenisa-
tion and studied the inﬂuence of emulsiﬁer type and concentration,
homogenisation pressure, temperature and number of cycles, pro-
duced b-carotene nanoemulsions with diameters ranging from 132
to 184 nm (determined by DLS).
An unstable formulation of nanoparticles can form agglomer-
ates and represent a risk to the health in the case of intravenous
administration of a drug-loaded nanoparticle suspension, leading
to blockage and embolism. The nanoparticle size control is a
parameter that must be ensured during storage, since one form
to verify if a nanoparticle formulation is physically stable is the
periodic determination of the mean diameter (Wu et al., 2011).
In the present work, no signiﬁcant differences were observed
(p < 0.05) between the volume-weighted diameters (D4.3) deter-
mined by number and volume (via LD) and the mean diameters
(z-diameter) measured by DLS. The bixin nanocapsules were con-
sidered stable because they did not exhibit any evidence of coales-
cence, creaming or ﬂocculation in either analysis (LD or DLS) over
119 days of storage at 25 C. These mechanisms of emulsion insta-
bility may be veriﬁed by an increase in mean particle diameter be-
cause the particles are in continual motion and collide with one
another under normal conditions.
Silva et al. (2011) produced b-carotene nanoemulsions distrib-
uted in a monomodal proﬁle with surface-weighted mean diame-
ter (D3,2) of 9.24 ± 0.16 nm and 228.63 ± 0.01 nm. The authors
veriﬁed the increase in the size of nanoemulsions in two formula-
tions, which varied from 9.24 ± 0.16 to 94.86 nm and from
10.27 ± 1.85 to 265.47 ± 120.86 nm after 21 days at 4 C, respec-
tively. They attributed the instability of the b-carotene nanoemul-
sions to the Brownian motion.
The bixin nanocapsule suspension was also considered physi-
cally stable regarding the mean diameter during the storage eval-
uated by laser diffraction (Fig. 5a) and dynamic light scattering
(Fig. 5b), since no signiﬁcant changes (p < 0.05) were observed in
the mean diameter and the particle size distributions also re-
mained constant, with no signiﬁcant changes (p < 0.05), at 0, 28,
63, 91 and 119 days of storage. Other authors attributed to the ste-
ric effect provided by the surfactant polysorbate 80 the responsi-
bility for the stability of this type of nanocapsule formulation
(Jäger et al., 2009; Venturini et al., 2011).
Yuan et al. (2008) studying the effects of production parame-
ters, developed b-carotene nanoemulsions with mean diameterFig. 5. Mean diameters of bixin nanocapsules evaluated by laser diffraction (a) and by dy
bixin nanocapsules at 0 (h) and 119 days ( ) of storage in ambient temperature. Stand(z-average) ranging from 132 to 184 nm that were stable for four
weeks in amber bottle ﬂushed with nitrogen and stored at 4 and
25 C. Tan and Nakajima (2005) veriﬁed that b-carotene nanodi-
spersions prepared using only Tween 20 as the emulsiﬁer re-
mained stable after 12 weeks of storage at 4 C in amber bottles.
Ribeiro et al. (2008) reported that the b-carotene nanoparticles
prepared using poly-D,L lactic acid and poly-D,L-lactic-co-glycolic
acid were stable over 5 months of storage at 4 C in the dark.
The decrease in bixin content during the ﬁrst days of storage
most likely occurred due to the formation of free radicals in the
oil (CCT) during the solubilisation of bixin in the organic phase
(40 C) (Tan & Nakajima, 2005) the presence of oxygen in the am-
ber bottles and the bixin release from the nanocapsule structure
during storage, which means free or unprotected bixin in the con-
tinuous phase (Jäger et al., 2009). From the 7th to the 28th day of
storage, there was no signiﬁcant variation in the bixin content
(p < 0.05) (Fig. 6).
After 119 days of storage, a bixin content of 45.7 ± 1.1% was ob-
served. This indicates that nanoencapsulation is highly effective in
inhibiting carotenoid loss during storage, although, decrease in
carotenoid content has also been demonstrated. Over 12 weeks
of storage at 4 C, the residual content of b-carotene in the nanod-
ispersions varied from 25.2% to 56% (Tan & Nakajima, 2005).
Using different parameters of encapsulation, Yuan et al. (2008)
produced and evaluated the stability of b-carotene nanoemulsions.
After 4 weeks of storage at 4 and 25 C, the residual b-carotene
concentration ranged from 75% to 86% of b-carotene. Yin, Chu,
Bobayashi, and Nakajima (2009) studied the effects of different
emulsiﬁers on the stability of b-carotene nanodispersions. After
4 months, the content of b-carotene fell from 45.6 to 63.3%.
Tan and Nakajima (2005) reported that the surface area, which
is higher in nanodispersions, was a contributing factor to b-caro-
tene loss, which is larger than in a b-carotene crystalline solution,
in addition to the formation of free radicals during the high-pres-
sure homogenisation process. Silva et al. (2011) attributed the de-
crease in the b-carotene content to the high surface area of the
nanoemulsions and the high degree of medium oxygenation occur-
ring during the homogenisation step. Yuan et al. (2008) suggested
that the degradation during storage may be a problem for the use
of high-pressure homogenisation in commercial products.
An alternative method for reducing the bixin degradation rate
in nanocapsules during storage might be to encapsulate bixin in
the same manner as described by Ribeiro et al. (2008), who re-
ported that the addition of a-tocopherol prevented b-carotene
loss; the authors reported that the b-carotene content remained
stable for at least 5 months. Qian et al. (2012) veriﬁed that the
incorporation of the water-soluble antioxidants EDTA and ascorbic
acid, and the oil-soluble vitamin E acetate, coenzyme Q10 reducednamic light scattering (c) over 119 days of storage and respective size distribution of
ard deviation is represented by bars.
Fig. 6. Variation of bixin content in bixin nanocapsule suspension over 119 days of
storage under ambient conditions. Standard deviations are represented by bars.
3912 K. B. S. Lobato et al. / Food Chemistry 141 (2013) 3906–3912the degradation rate of b-carotene nanoemulsions under acceler-
ated storage conditions (50 C). These authors also reported that
the addition of water- and oil-soluble antioxidants did not affect
the particle size.
4. Conclusions
Bixin is an antioxidant and the predominant pigment found in
fat-soluble preparations that are used to colourise butter, cheese,
bakery products, oils, ice creams, sausages, cereals and extruded
products. The technique of interfacial deposition of preformed
polymer allowed for the production of bixin nanocapsules with
high encapsulation efﬁciency (100%), satisfactory volume-
weighted diameter (D4,3) of 195 ± 27 nm and monomodal distribu-
tions. No signiﬁcant changes (p < 0.05) were observed in the parti-
cle diameter over 119 days of storage when evaluated using both
LD and DLS. The decrease in the pH levels most likely occurred
due to poly-e-caprolactone hydrolysis and the decrease in the bixin
content most likely occurred due to poly-e-caprolactone hydrolysis
and the formation of free radicals, high surface area of the nano-
capsules, and the presence of oxygen in the bottles. The solubilisa-
tion of bixin in aqueous media enhances the future possibility of
using bixin in low-fat foods and in studies performed to evaluate
its effects in vivo, which may expand the breadth of bixin’s indus-
trial application.
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